FinalDose
YC Sp26Programmable DNA drug destroying all cancers, unlocking 80% of targets
London, England, United KingdomFounded 20265 employeesfinaldose.ai
Team
5
Founded
2026
About
FinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.
Tags
No open roles at this time.
Similar Healthcare startups
Nuntius Therapeutics
Cell-specific genetic medicines
Gene TherapyNanomedicine
Open Jobs —
Team 2
Founded 2021
Sixfold Bioscience
Delivering RNA therapies.
Gene TherapyNanomedicineDrug Delivery
Open Jobs —
Team 27
Founded 2017
WhiteLab Genomics
Unleashing the potential of DNA and RNA based therapies using AI
Artificial IntelligenceGene TherapyCell Therapy
Open Jobs —
Team 40
Founded 2022
Taiga
Autonomous medical billing
Artificial Intelligence
Open Jobs —
Team 2
Founded 2026